查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1919337

超音波品質保證模型市場（按模型類型、材質、應用和最終用戶分類）—2026-2032年全球預測

Ultrasound QA Phantoms Market by Phantom Type, Material, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年超音波品質保證模型市值為 1.9948 億美元，預計到 2026 年將成長至 2.1827 億美元，複合年成長率為 6.38%，到 2032 年將達到 3.0762 億美元。

關鍵市場統計數據
基準年 2025 1.9948億美元
預計年份：2026年 2.1827億美元
預測年份 2032 3.0762億美元
複合年成長率 (%) 6.38%

超音波品質保證模型全面介紹：重點關注臨床需求、技術促進因素、監管壓力和優先事項

超音波品質保證模型是臨床、學術和製造環境中確保診斷準確性、設備可靠性和操作人員能力的重要工具。這些工程模型模擬組織特性，校正影像系統，並檢驗多普勒測量結果，從而實現可重複的性能檢查，確保病患安全和提升診斷信心。隨著超音波應用在各個專科領域的日益普及，模型的作用也從簡單的校準目標演變為支援先進成像模式和符合監管要求的複雜模擬器。

人工智慧、尖端材料、混合測試方法以及日益嚴格的監管要求正在推動超音波體檢驗的變革性轉變

超音波模體領域正經歷變革時期，其驅動力來自於技術進步、臨床工作流程的改變以及新型製造技術的整合。人工智慧和演算法影像處理技術的進步推動了對能夠在不同掃描儀型號和軟體版本中提供一致、可重複標準的模體的需求。同時，結合實體模體數位雙胞胎的混合測試方法和擴展檢驗通訊協定正變得越來越重要，使開發人員和臨床團隊能夠將類比、台架測試和現場性能評估連接起來，形成閉迴路。

評估2025年美國關稅對超音波品質保證模型供應鏈、零件採購和製造成本的影響

2025年生效的美國關稅對全球供應鏈產生了累積影響，直接影響超音波保證模型製造所需零件的供應和穩定性。由於許多模型依賴進口原料、精密零件和專用製造材料，關稅上調及相關貿易措施改變了籌資策略，並增加了跨境採購的實際複雜性。為此，製造商正在重新評估其供應商組合，優先考慮關鍵零件的近岸採購，並尋找既能保持性能又能減少對受關稅影響進口產品依賴的替代材料。

對模型類型、材料選擇、應用重點和最終用戶畫像的細分洞察會影響技術優先順序和購買行為。

對這種細分市場的詳細分析揭示了不同的技術和商業性路徑如何影響產品設計、採購和最終應用。按模型類型分類，產品包括用於常規系統檢查的順應性模型、專用於流量和速度檢驗的多普勒模型、用於剛度映射的彈性成像模型、用於受控流體動態測試的流動模型以及可模擬聲學和散射特性的組織模擬模型。每種類型的模型對材料均勻性、目標幾何形狀和使用壽命穩定性都有不同的要求，這些技術要求直接體現在買賣雙方的規格討論中。

對美洲、歐洲、中東和非洲以及亞太地區的需求趨勢、供應動態、監管因素和創新情況進行區域性洞察

區域趨勢對品質保證模型領域的採購政策、法規要求和創新路徑有顯著影響。在美洲，市場需求著重於臨床吞吐量和符合認證機構的要求，這要求供應商優先提供功能強大、易於使用且能順利整合到高頻診斷環境中的模型。此外，由於接近性大型醫院系統和密集的診斷中心網路，物流、快速更換週期和服務水準保證也成為關注的重點。

分析主要企業如何透過工程實力、夥伴關係關係、嚴格的品質通訊協定和商業化策略來推進超音波保證模型的發展。

超音波模體領域的主要企業憑藉深厚的工程技術、靈活的供應鏈以及將產品設計與檢驗的性能數據相結合的能力而脫穎而出。一些製造商專注於材料科學創新，以生產出更耐用、聲學保真度更高的模體；而另一些製造商則將模組化和易於整合到臨床工作流程中作為其核心競爭優勢。與成像設備製造商和研究機構建立策略合作夥伴關係已成為共同開發解決方案的關鍵途徑，這些解決方案能夠直接與設備功能和軟體更新相匹配，從而實現測試模型與特定成像平台要求的緊密契合。

為產業領導者提供切實可行的建議，以加強品質保證模型開發、提高供應鏈韌性並加速臨床整合

我們鼓勵行業領導者採取一系列切實可行的舉措，使其產品系列與不斷變化的臨床需求和供應實際情況相適應。首先，優先投資於能夠延長模型使用壽命並增強高級模型逼真度的材料和設計。這將有助於開展高保真度的培訓和評估，同時降低臨床客戶的整體擁有成本。其次，考慮實現供應商多元化，並發展區域生產夥伴關係，以降低貿易摩擦風險並縮短前置作業時間。結合嚴格的庫存計劃，這些措施將提高營運韌性。

透明的調查方法，解釋了資料收集、檢驗通訊協定、相關人員訪談、實驗室測試方法和分析框架。

本報告的研究結合了與關鍵相關人員的對話、實驗室驗證以及對第二手資料的整合，以確保得出可靠且可操作的結論。主要資料收集工作包括對臨床使用者、採購專業人員、學術研究人員和產品開發團隊進行結構化檢驗，以全面了解操作人員培訓、效能評估和系統校準等方面的需求。同時，實驗室測試通訊協定在標準化條件下，針對代表性模型類型檢驗了聲學保真度、耐久性和可重複性等關鍵指標，確保技術評估具有可重複性，並與實際應用環境相關。

一份權威的綜合報告，重點闡述了品質保證模型在臨床實踐、研究重點、生產策略和合作方面的意義，以提高其有效性。

技術趨勢、供應鏈發展、市場細分洞察和區域趨勢的整合，為臨床實踐、產品開發和籌資策略提供了明確的啟示。臨床醫生和培訓主管應優先選擇與特定設備要求和操作流程高度匹配的模型，以最大限度地提高培訓效果和診斷一致性。研究人員和學術團隊可以利用先進的材料選擇和模組化模型結構，設計可重複且適用於不同設備的通用研究。同時，製造商必須在創新與可驗證的可重複性和高品質文件之間取得平衡，以滿足機構的期望。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依模體類型分類的超音波品質保證模體市場

  • 遵守
  • 多普勒
  • 彈性成像
  • 流動
  • 組織擬態

第9章超音波品質保證模體市場（依材料分類）

  • 瓊脂
  • 凝膠蠟
  • 聚氯乙烯塑性溶膠

第10章超音波品質保證模體市場（依應用領域分類）

  • 操作員培訓
  • 績效評估
  • 系統校準

第11章超音波品質保證模體市場（以最終用戶分類）

  • 學術和研究機構
  • 診斷中心
  • 醫院和診所
  • 原始設備製造商

第12章 各地區超音波品質保證模體市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章超音波品質保證模組市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國超音波品質保證模體市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國超音波品質保證模型市場

第16章：中國超音波品質保證模體市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Acertara Acoustic Laboratories, LLC
  • Advanced Technical Systems, Inc.
  • B&L Engineering
  • CIRS, Inc.
  • Computerized Imaging Reference Systems, Inc.
  • DATASCIENCE International
  • GAMMEX, Inc.
  • General Research of Electronics, Inc.
  • Imaging Phantom Services LLC
  • Kyoto Electronics Manufacturing Co., Ltd.
  • Odel, Inc.
  • Penta Incorporated
  • Phantom Laboratory, Inc.
  • Sun Nuclear Corporation
Product Code: MRR-F14BA1B341C9

The Ultrasound QA Phantoms Market was valued at USD 199.48 million in 2025 and is projected to grow to USD 218.27 million in 2026, with a CAGR of 6.38%, reaching USD 307.62 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 199.48 million
Estimated Year [2026] USD 218.27 million
Forecast Year [2032] USD 307.62 million
CAGR (%) 6.38%

Comprehensive introduction to ultrasound quality assurance phantoms highlighting clinical needs, technological drivers, regulatory pressures, and priorities

Ultrasound quality assurance phantoms serve as foundational tools across clinical, academic, and manufacturing environments, ensuring diagnostic accuracy, device reliability, and operator competency. These engineered test objects mimic tissue properties, calibrate imaging systems, validate Doppler measurements, and enable reproducible performance checks that underpin patient safety and diagnostic confidence. As ultrasound applications proliferate across specialties, the role of phantoms has evolved from simple calibration objects to sophisticated simulators that support advanced modalities and regulatory compliance.

Consequently, stakeholders from hospitals and diagnostic centers to academic and research institutes and original equipment manufacturers rely on phantoms not only to confirm device operation but also to support training, quality management systems, and product development cycles. In parallel, advances in materials science and imaging technologies have raised expectations for realism, repeatability, and long-term stability. Therefore, an informed introduction to this landscape must connect technical capabilities with clinical needs, operational constraints, and procurement realities, enabling leaders to align specifications with intended use cases. By framing the primary functions, current pressures, and emerging priorities, this section establishes the baseline understanding required for more detailed analysis that follows.

Transformative shifts reshaping ultrasound phantom validation driven by AI, advanced materials, hybrid testing methods, and heightened regulatory expectations

The ultrasound phantom landscape is undergoing a period of transformation driven by converging technological advances, shifting clinical workflows, and novel manufacturing techniques. Artificial intelligence and algorithmic image processing have heightened demand for phantoms that provide consistent, reproducible reference standards across diverse scanner models and software versions. Simultaneously, hybrid testing approaches that combine physical phantoms with digital twins and augmented validation protocols are becoming more prominent, enabling developers and clinical teams to close the loop between simulation, bench testing, and in-field performance assessment.

Material innovations, including composites and improved polymer formulations, now deliver longer-lasting, more tissue-realistic targets for elastography and Doppler validation. In addition, modular phantom architectures support interchangeable inserts for multi-parametric validation, which reduces inventory burdens and increases testing flexibility. Regulatory expectations and an emphasis on standardized protocols have also compelled suppliers to document test repeatability and traceability more rigorously. As a result, manufacturers and end users are recalibrating procurement criteria to favor products that combine technical rigor with operational adaptability, while clinical teams prioritize phantoms that align closely with real-world imaging conditions and workflow constraints.

Assessment of 2025 United States tariff effects on supply chains, component sourcing, and manufacturing costs affecting availability and resilience of QA phantoms

Tariff measures enacted by the United States in 2025 have produced cumulative effects across global supply chains that directly influence the availability and resilience of components used in ultrasound QA phantom production. Many phantoms rely on imported raw materials, precision components, and specialized manufacturing inputs; consequently, elevated duties and related trade measures have altered sourcing strategies and increased the practical complexity of cross-border procurement. In response, manufacturers have reassessed supplier portfolios, prioritized nearshoring for critical components, and explored alternate material selections that preserve performance while reducing dependency on tariff-affected imports.

Beyond immediate procurement impacts, these trade actions have influenced lead times and vendor relationships, prompting buyers to place longer planning horizons on orders and to invest in buffer inventories where feasible. Moreover, suppliers have adapted pricing and contractual terms to account for tariff pass-through and to maintain predictable delivery commitments. In parallel, increased attention to domestic certification and compliance requirements has accelerated conversations about localized production capacity. Together, these changes have encouraged a more strategic approach to sourcing decisions, placing resilience and supplier diversity at the center of procurement and product development planning for QA phantoms.

Segmentation insights on phantom type, material selection, application focus, and end user profiles that influence technical priorities and purchasing behavior

A granular view of segmentation reveals how distinct technical and commercial pathways shape product design, procurement, and end use. When distinguishing by phantom type, offerings encompass compliance phantoms for routine system checks, Doppler phantoms tailored to flow and velocity validation, elastography phantoms designed for stiffness mapping, flow phantoms for controlled fluid dynamics testing, and tissue mimicking phantoms that replicate acoustic and scattering properties. Each type imposes different requirements for material homogeneity, target geometry, and lifetime stability, and these technical demands translate directly into specification conversations between purchasers and suppliers.

Material selection further differentiates product lines: commonly used substrates include agar formulations prized for acoustic fidelity, gel wax variants that balance durability and handling, and PVC plastisol solutions that offer extended shelf life and manufacturing consistency. These material choices influence the ease of customization, transportability, and storage protocols. Applications also govern design trade-offs: operator training phantoms emphasize anatomical realism and repeatable pathology simulation, performance evaluation tools prioritize measurement accuracy and statistical repeatability, and system calibration assets focus on standardized targets and traceable markers. End user classification shapes purchasing priorities and service expectations; academic and research institutes may prioritize versatility and documentation for reproducible studies, diagnostic centers often emphasize throughput and cost efficiency, hospitals and clinics require durable, low-maintenance solutions aligned with clinical workflows, and original equipment manufacturers look for integration-ready phantoms that support product validation and warranty processes. Collectively, these segmentation lenses clarify where value accrues and where product refinement yields the greatest operational impact.

Regional insights into demand, supply dynamics, regulatory drivers, and innovation across Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics exert a strong influence on procurement preferences, regulatory expectations, and innovation pathways in the QA phantom domain. In the Americas, demand emphasizes clinical throughput and compliance with established accrediting bodies; this environment encourages suppliers to prioritize robust, easy-to-use phantoms that integrate smoothly into high-volume diagnostic settings. In addition, proximity to large hospital systems and a dense network of diagnostic centers drives a focus on logistics, rapid replacement cycles, and service-level commitments.

Conversely, Europe, Middle East & Africa presents a mosaic of regulatory regimes and clinical practices that reward adaptable product families and strong technical documentation. Suppliers operating in this region must navigate varying standards while offering modular solutions that can be customized for differing clinical norms and training programs. Meanwhile, Asia-Pacific demonstrates accelerated adoption of advanced imaging modalities and rapid expansion of academic and clinical infrastructure, which stimulates demand for phantoms that support advanced modalities such as elastography and high-frequency imaging. Across all regions, however, regulatory harmonization efforts and increasing emphasis on reproducibility incentivize suppliers to deliver transparent product validation data and to develop regional support networks that reduce lead times and improve in-country service responsiveness.

Analysis of leading companies advancing ultrasound QA phantoms via engineering strengths, partnerships, rigorous quality protocols, and commercialization strategies

Leading companies in the ultrasound phantom space are differentiating through engineering depth, supply chain agility, and the ability to couple product design with validated performance data. Some manufacturers emphasize materials science innovations to produce phantoms with improved longevity and acoustic fidelity, while others center their competitive positioning on modularity and ease of integration into clinical workflows. Strategic partnerships with imaging OEMs and research institutions have become a vital route to co-develop solutions that map directly to device capabilities and software updates, enabling closer alignment between test artifacts and the requirements of specific imaging platforms.

Furthermore, firms that invest in rigorous quality assurance protocols and transparent validation reporting create stronger credibility among clinical customers and regulatory stakeholders. Companies that maintain diversified manufacturing footprints and robust distribution networks also demonstrate superior responsiveness to procurement cycles and supply disruptions. As purchasers increasingly seek documented repeatability and traceability, vendors that can provide detailed test reports, long-term stability data, and calibration support stand to capture preference among sophisticated buyers. Collectively, these strategic directions indicate that competitive advantage arises from a blend of technical excellence, partnership ecosystems, and operational reliability.

Practical recommendations for industry leaders to strengthen development, improve supply resilience, and accelerate clinical integration of QA phantoms

Industry leaders should pursue a suite of pragmatic actions to align product portfolios with evolving clinical needs and supply realities. First, prioritize investments in materials and design that extend phantom longevity and enhance realism for advanced modalities; this will reduce total cost of ownership for clinical customers while supporting high-fidelity training and evaluation. Second, diversify supplier bases and consider regional production partnerships to mitigate exposure to trade actions and to shorten lead times; in combination with denser inventory planning, these steps will improve operational resilience.

Third, strengthen collaboration with imaging system manufacturers and academic partners to co-develop validation protocols that reflect contemporary software and hardware configurations, thereby enhancing the relevance of phantoms for both product development and clinical training. Fourth, expand documentation and certification offerings to meet the expectations of regulators and institutional purchasers; detailed validation data and traceable calibration procedures will accelerate adoption and simplify procurement. Finally, adopt flexible commercialization models, including modular bundles and service agreements that allow buyers to scale capability incrementally. By implementing these recommendations, suppliers and institutional buyers can better navigate technical complexity, regulatory demands, and supply chain constraints while delivering consistent, clinically relevant outcomes.

Transparent research methodology describing data collection, validation protocols, stakeholder interviews, laboratory testing approaches, and analytical frameworks

The research underpinning this report combines primary stakeholder engagement, laboratory verification, and secondary source synthesis to ensure robust, actionable findings. Primary data collection included structured interviews with clinical users, procurement specialists, academic investigators, and product development teams, enabling a nuanced view of requirements across operator training, performance evaluation, and system calibration contexts. In parallel, laboratory testing protocols verified key claims around acoustic fidelity, durability, and repeatability for representative phantom types under standardized conditions, ensuring that technical evaluations are reproducible and relevant to real-world use.

Secondary research supported contextual analysis of materials trends and supply chain patterns, drawing on regulatory guidance and industry best practices to frame compliance and documentation expectations. Validation steps included cross-referencing interview insights with laboratory outcomes and supplier documentation to reconcile observed performance with stated specifications. Analytical frameworks emphasized segmentation across phantom type, material, application, and end user to reveal actionable differentials. Together, these methods provide a transparent foundation for the conclusions and recommendations presented, and they enable stakeholders to trace findings back to source inputs and validation steps.

Conclusive synthesis highlighting implications for clinical practice, research priorities, manufacturing strategy, and collaboration to advance QA phantom effectiveness

The synthesis of technical trends, supply chain developments, segmentation insights, and regional dynamics yields clear implications for clinical practice, product development, and procurement strategy. Clinicians and training directors should prioritize phantoms that align closely with modality-specific requirements and operational workflows to maximize training efficacy and diagnostic consistency. Researchers and academic groups can leverage advanced material options and modular phantom architectures to design reproducible studies that generalize across devices, while manufacturers should balance innovation with demonstrable repeatability and quality documentation to meet institutional expectations.

From a strategic perspective, supply chain resilience and supplier diversification have emerged as central priorities in light of trade policy changes and component concentration. At the same time, collaboration between vendors, OEMs, and clinical stakeholders will accelerate development of validation protocols that map directly to device functionality. In sum, a coordinated approach that integrates technical rigor, operational adaptability, and transparent documentation will best position organizations to derive reliable value from ultrasound QA phantoms and to support improved diagnostic outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Ultrasound QA Phantoms Market, by Phantom Type

  • 8.1. Compliance
  • 8.2. Doppler
  • 8.3. Elastography
  • 8.4. Flow
  • 8.5. Tissue Mimicking

9. Ultrasound QA Phantoms Market, by Material

  • 9.1. Agar
  • 9.2. Gel Wax
  • 9.3. PVC Plastisol

10. Ultrasound QA Phantoms Market, by Application

  • 10.1. Operator Training
  • 10.2. Performance Evaluation
  • 10.3. System Calibration

11. Ultrasound QA Phantoms Market, by End User

  • 11.1. Academic & Research Institutes
  • 11.2. Diagnostic Centers
  • 11.3. Hospitals & Clinics
  • 11.4. Original Equipment Manufacturers

12. Ultrasound QA Phantoms Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Ultrasound QA Phantoms Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Ultrasound QA Phantoms Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Ultrasound QA Phantoms Market

16. China Ultrasound QA Phantoms Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Acertara Acoustic Laboratories, LLC
  • 17.6. Advanced Technical Systems, Inc.
  • 17.7. B&L Engineering
  • 17.8. CIRS, Inc.
  • 17.9. Computerized Imaging Reference Systems, Inc.
  • 17.10. DATASCIENCE International
  • 17.11. GAMMEX, Inc.
  • 17.12. General Research of Electronics, Inc.
  • 17.13. Imaging Phantom Services LLC
  • 17.14. Kyoto Electronics Manufacturing Co., Ltd.
  • 17.15. Odel, Inc.
  • 17.16. Penta Incorporated
  • 17.17. Phantom Laboratory, Inc.
  • 17.18. Sun Nuclear Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ULTRASOUND QA PHANTOMS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ULTRASOUND QA PHANTOMS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ULTRASOUND QA PHANTOMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ULTRASOUND QA PHANTOMS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY COMPLIANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY COMPLIANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY COMPLIANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY DOPPLER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY DOPPLER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY DOPPLER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY ELASTOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY ELASTOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY ELASTOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY TISSUE MIMICKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY TISSUE MIMICKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY TISSUE MIMICKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY AGAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY AGAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY AGAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY GEL WAX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY GEL WAX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY GEL WAX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY PVC PLASTISOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY PVC PLASTISOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY PVC PLASTISOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY OPERATOR TRAINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY OPERATOR TRAINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY OPERATOR TRAINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY PERFORMANCE EVALUATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY PERFORMANCE EVALUATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY PERFORMANCE EVALUATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY SYSTEM CALIBRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY SYSTEM CALIBRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY SYSTEM CALIBRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY ORIGINAL EQUIPMENT MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY ORIGINAL EQUIPMENT MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY ORIGINAL EQUIPMENT MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS ULTRASOUND QA PHANTOMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. MIDDLE EAST ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. AFRICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. AFRICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. ASEAN ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. ASEAN ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. ASEAN ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 96. ASEAN ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. ASEAN ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. GCC ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GCC ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. GCC ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 101. GCC ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. GCC ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPEAN UNION ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPEAN UNION ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPEAN UNION ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPEAN UNION ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPEAN UNION ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. BRICS ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. BRICS ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. BRICS ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 111. BRICS ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. BRICS ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. G7 ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. G7 ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. G7 ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 116. G7 ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. G7 ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. NATO ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. NATO ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. NATO ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 121. NATO ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. NATO ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. UNITED STATES ULTRASOUND QA PHANTOMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 125. UNITED STATES ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. UNITED STATES ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 127. UNITED STATES ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. UNITED STATES ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. CHINA ULTRASOUND QA PHANTOMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 130. CHINA ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. CHINA ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 132. CHINA ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. CHINA ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)